InvestorsHub Logo

Monroe1

05/24/23 11:05 AM

#220434 RE: Buddyboy20 #220426

Bingo!!

Sponsor: Cytodyn, Inc.....Last modified: 23 May 2023
SUMMARY:
The primary objectives of the trial are to assess the EfficacyClinical Safety and Tolerability parameters of PRO140 in combination with failing ART during the initial one-week treatment period and in combination with Optimized Background Therapy during the subsequent 24-week treatment period.



$CYDY$
Bullish
Bullish